For the second year in a row, Justin Danhof questions Merck CEO Kenneth Frazier about the company's support for Obamacare. First, Danhof calls the pharmaceutical giant out on backing legislation that will likely be deemed unconstitutional and asks what protections the company has installed, if any, to avoid doing so in the future. Then, he follows up on last year's call for transparency in Merck's allocation of shareholder money to support PhRMA and, thus, their financial share of the Association's $150 million-dollar advertising campaign that promoted and assisted in the passage of Obamacare.